Uttl, L.; Hložek, T.; Mareš, P.; Páleníček, T.; Kubová, H.
Anticonvulsive Effects and Pharmacokinetic Profile of Cannabidiol (CBD) in the Pentylenetetrazol (PTZ) or N-Methyl-D-Aspartate (NMDA) Models of Seizures in Infantile Rats. Int. J. Mol. Sci. 2022, 23, 94.
https://doi.org/10.3390/ijms23010094
AMA Style
Uttl L, Hložek T, Mareš P, Páleníček T, Kubová H.
Anticonvulsive Effects and Pharmacokinetic Profile of Cannabidiol (CBD) in the Pentylenetetrazol (PTZ) or N-Methyl-D-Aspartate (NMDA) Models of Seizures in Infantile Rats. International Journal of Molecular Sciences. 2022; 23(1):94.
https://doi.org/10.3390/ijms23010094
Chicago/Turabian Style
Uttl, Libor, Tomáš Hložek, Pavel Mareš, Tomáš Páleníček, and Hana Kubová.
2022. "Anticonvulsive Effects and Pharmacokinetic Profile of Cannabidiol (CBD) in the Pentylenetetrazol (PTZ) or N-Methyl-D-Aspartate (NMDA) Models of Seizures in Infantile Rats" International Journal of Molecular Sciences 23, no. 1: 94.
https://doi.org/10.3390/ijms23010094
APA Style
Uttl, L., Hložek, T., Mareš, P., Páleníček, T., & Kubová, H.
(2022). Anticonvulsive Effects and Pharmacokinetic Profile of Cannabidiol (CBD) in the Pentylenetetrazol (PTZ) or N-Methyl-D-Aspartate (NMDA) Models of Seizures in Infantile Rats. International Journal of Molecular Sciences, 23(1), 94.
https://doi.org/10.3390/ijms23010094